British Columbia Investment Management Corp Bei Gene, Ltd. Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$121.11 - $216.05 $142,304 - $253,858	-1,175 Reduced 5.74%	19,300 $3.12 Million
Q1 2022 May 12, 2022	BUY	$146.52 - $269.56 $172,161 - $316,733	1,175 Added 6.09%	20,475 $3.86 Million
Q4 2021 Feb 11, 2022	BUY	$248.56 - $389.34 $24,856 - $38,934	100 Added 0.52%	19,300 $5.23 Million
Q2 2021 Aug 09, 2021	SELL	$292.75 - $367.01 $58,550 - $73,402	-200 Reduced 1.03%	19,200 $6.59 Million
Q4 2020 Feb 02, 2021	BUY	$221.31 - $316.61 $3.96 Million - $5.67 Million	17,900 Added 1193.33%	19,400 $5.01 Million
Q3 2020 Nov 10, 2020	SELL	$189.18 - $286.44 $18,918 - $28,644	-100 Reduced 6.25%	1,500 $430,000
Q2 2020 Aug 12, 2020	SELL	$123.9 - $195.41 $99,120 - $156,328	-800 Reduced 33.33%	1,600 $301,000
Q1 2020 May 13, 2020	SELL	$121.84 - $173.19 $182,760 - $259,785	-1,500 Reduced 38.46%	2,400 $295,000
Q4 2019 Feb 12, 2020	SELL	$115.78 - $208.34 $1.9 Million - $3.42 Million	-16,438 Reduced 80.82%	3,900 $646,000
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $1.33 Million - $1.63 Million	11,000 Added 117.8%	20,338 $2.49 Million
Q2 2019 Aug 12, 2019	SELL	$113.99 - $146.86 $182,384 - $234,976	-1,600 Reduced 14.63%	9,338 $1.16 Million
Q1 2019 May 08, 2019	BUY	$122.82 - $151.83 $717,023 - $886,383	5,838 Added 114.47%	10,938 $1.44 Million
Q4 2018 Feb 13, 2019	BUY	$107.01 - $175.15 $545,751 - $893,265	5,100 New	5,100 $715,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$1.89 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.15 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$927 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$891 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$664 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account